Mariner’s Clover Health Investments CLOV Stock Holding History

Mariner’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-22,006	Closed	-$20K	–	2805
2022 Q4	$20K	Buy	+22,006	New	+$29.4K	﹤0.01%	2683

Other funds holding CLOV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

Mariner's CLOV Position: Q1 2023 in Review

Mariner sold out of Clover Health Investments (CLOV) in Q1 2023, closing a stake of 22,006 shares — an estimated $20K sold.

Mariner first reported a position in CLOV in Q4 2022 and held it in 1 quarter. The position peaked at $20K in Q4 2022. 157 funds tracked by Wall St. Rank hold CLOV as of Q1 2023.

Mariner reported no remaining Clover Health Investments position as of Q1 2023 after selling out during the quarter.
Mariner sold 22,006 Clover Health Investments shares in Q1 2023, an estimated $20K.
Mariner first reported a position in Clover Health Investments in Q4 2022 and held it in 1 quarter.
Mariner's Clover Health Investments position peaked at $20K in Q4 2022.
157 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2023.

Based on Mariner's 13F filing for Q1 2023, filed 15 May 2023.